![](/images/graphics-bg.png)
The Management of Cardiovascular Risk through Epigenetic Biomarkers
Joint Authors
de Franciscis, Stefano
Metzinger, Laurent
Serra, Raffaele
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-07-13
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Epigenetic sciences study heritable changes in gene expression not related to changes in the genomic DNA sequence.
The most important epigenetic mechanisms are DNA methylation, posttranslational histone modification, and gene regulation by noncoding RNAs, such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs).
Cardiovascular diseases (CVD) are responsible for at least one-third of premature deaths worldwide and represent a heavy burden of healthcare expenditure.
We will discuss in this review the most recent findings dealing with epigenetic alterations linked to cardiovascular physiopathology in patients.
A particular focus will be put on the way these changes can be translated in the clinic, to develop innovative and groundbreaking biomarkers in CVD field.
American Psychological Association (APA)
Metzinger, Laurent& de Franciscis, Stefano& Serra, Raffaele. 2017. The Management of Cardiovascular Risk through Epigenetic Biomarkers. BioMed Research International،Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1139371
Modern Language Association (MLA)
Metzinger, Laurent…[et al.]. The Management of Cardiovascular Risk through Epigenetic Biomarkers. BioMed Research International No. 2017 (2017), pp.1-6.
https://search.emarefa.net/detail/BIM-1139371
American Medical Association (AMA)
Metzinger, Laurent& de Franciscis, Stefano& Serra, Raffaele. The Management of Cardiovascular Risk through Epigenetic Biomarkers. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1139371
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1139371